Add To Watchlist

ASTRAZENECA

The Wire

AstraZeneca quarterly earns up 22 percent

Pharmaceutical company AstraZeneca PLC posted a 22 percent rise in third quarter net profit on Thursday, boosted by initial sales of its swine flu vaccine and delayed entry of generic drug competition in the United States.

Drugmaker AstraZeneca cutting its US sales force

British drugmaker AstraZeneca PLC plans to cut its U.S. sales force by offering buyouts.

AstraZeneca loses price inflation lawsuit appeal

An appeals court on Wednesday upheld a lower court's ruling that AstraZeneca inflated the price of expensive drugs in Massachusetts.

Forest Laboratories, AstraZeneca sign partnership

Forest Laboratories Inc. and AstraZeneca said Wednesday they are collaborating to develop and sell a next-generation treatment for antibiotic-resistant, or Staph, infections and hospital-acquired pneumonia.

Astra 2Q profit up 6 pct as it cuts costs

Pharmaceutical company AstraZeneca PLC posted a 6 percent rise in second quarter net profit on Thursday as the company weathered the global recession better than feared and some of its key drugs benefited from a lack of generic competition.

AstraZeneca, Merck collaborate on cancer treatment

AstraZeneca PLC and Merck & Co. said Monday they will jointly develop a pair of drugs meant to hit cancer with a one-two punch, part of a growing trend of combination cancer treatments.

AstraZeneca e-mails show debate on Seroquel risks

Marketing executives at British drugmaker AstraZeneca PLC for years blocked efforts by company scientists to raise concerns antipsychotic drug Seroquel caused weight gain and other problems, saying that would harm sales, plaintiff lawyers say.

Seroquel user wants judge to unseal papers for FDA

A patient who claims the psychiatric drug Seroquel gave him diabetes has asked a judge to unseal maker AstraZeneca's confidential documents about its side effects before U.S. regulators decide whether to approve a version of the drug for millions of new patients.

Documents on Seroquel show drugmaker knew of risks

Internal AstraZeneca reports and e-mails written by company officials show they knew a decade ago that their psychiatric drug Seroquel caused diabetes and major weight gain, plaintiffs' lawyers said Friday after releasing dozens of the previously sealed documents.

Company seeks approval for nasal spray flu vaccine

Drugmaker AstraZeneca submitted a new drug application with European Union authorities to market a nasal spray vaccine against the flu, the company said Tuesday.

AstraZeneca says FDA asks for Seroquel detail

AstraZeneca PLC said Wednesday that the U.S. Food and Drug Administration has asked for more information regarding the drug Seroquel, which AstraZeneca is trying to get approved for use by people suffering from depression.

Infosys wins deal from AstraZeneca

British drug maker AstraZeneca PLC has awarded India's Infosys Technologies Ltd. a five-year, multimillion dollar contract for information technology work, the companies said Monday.

AstraZeneca extends diabetes drug plans to Japan

AstraZeneca PLC and Bristol-Myers Squibb Co. said Monday they plan to extend their international deal to co-develop — and ultimately sell — a new diabetes drug to include Japan.

AstraZeneca's new lung drug may face US delay

AstraZeneca PLC could have to delay the rollout of its new infant lung drug in the United States because the Food and Drug Administration has asked for more information about the medicine before allowing it on the market.

AstraZeneca plans to end Abraxis deal

AstraZeneca PLC and U.S.-based Abraxis BioScience Inc. are considering ending their two-year marketing deal for breast cancer treatment Abraxane in the United States.

AstraZeneca wins first round in Teva litigation

AstraZeneca PLC said Thursday it has been granted a temporary restraining order in a U.S. court to halt the launch of a generic version of its child asthma medication Pulmicort Respules by rival Teva Pharmaceutical Industries Ltd.

AstraZeneca to cut jobs, close plants in Europe

Pharmaceutical company AstraZeneca PLC said Thursday it plans to close three plants in Spain, Belgium and Sweden and cut 1,400 jobs in Europe by 2013 to improve efficiency and expand investment in Asia to serve the growing market there.

AstraZeneca wins first round in Teva litigation

AstraZeneca PLC won the first round of a legal fight over the release of a generic version of its child asthma medication Pulmicort Respules by rival Teva Pharmaceutical Industries Ltd. on Thursday as it also unveiled job cuts in Europe.

AstraZeneca 3Q profits up 29 percent

Pharmaceutical company AstraZeneca PLC posted a 29 percent rise in third quarter net profit on Thursday as strong sales in emerging markets like China helped offset flat demand for its products in the United States.

AstraZeneca Settles Ranbaxy Lawsuit

Shares in pharmaceutical company AstraZeneca PLC soared Tuesday on news that an agreement with an Indian company will delay the release of a generic competitor to its best selling heartburn drug for six years.

FDA Gives OK for Schizophrenia Treatment

AstraZeneca PLC said Monday that it has received approval from the U.S. Food and Drug Administration for a new formulation of its popular Seroquel schizophrenia treatment, making it the first medicine to treat both the manic and depressive sides of bipolar disorder.

The Vine
AstraZeneca admitts Seroquel/diabetes link in Japan, denied it in U.S.
Source: industry.bnet.com

An AstraZeneca saleswoman told a U.S. doctor the antipsychotic Seroquel didn't cause diabetes almost four years after the company warned Japanese physicians about the drug's links to the disease, internal documents show.

AstraZeneca Can't Stop Damaging Testimony by Seroquel Expert Witness --6000 cases effected
Source: Bloomberg.com

AstraZeneca, based in London, sought to have Donna Arnett -an expert witness, disqualified, saying she cherry-picked data favorable to her opinion.

AstraZeneca faces litigation over disclosure of knowledge about obesity & diabetes
Source: http://tmap.wordpress.com

E-mail trail shows Seroquel maker AstraZeneca knew drug caused obese weight gain & diabetes for 10 years.

Documents: AstraZeneca hid study results to sell Seroquel - St. Petersburg Times
Source: shar.es

Behind the scenes at the global pharmaceutical company AstraZeneca, the team in charge of the blockbuster antipsychotic Seroquel had one mission: make the multibillion-dollar seller even bigger.

Tons of Industry Released Drugs Taint US Water: AP Report
Source: Yahoo! News

U.S. manufacturers, including major drugmakers, have legally released at least 271 million pounds of pharmaceuticals into waterways that often provide drinking water, contamination the federal government has consistently overlooked, according to an Associated Press investigation.

A Silenced Drug Study Creates An Uproar
Source: The Washington Post

The study would come to be called "cursed," but it started out just as Study 15.

Don't let drugmaker hide records
Source: St. Petersburg Times > Local News

Thousands of personal injury lawsuits have been filed against AstraZeneca by patients who claim the drug led to weight gain and diabetes.

Facing numerous Seroquel lawsuits, drugmaker AstraZeneca releases documents
Source: St. Petersburg Times > Local News

The public got a glimpse into the inner workings of a global pharmaceutical company Friday when AstraZeneca released more than 100 sealed documents in a tsunami of lawsuits claiming its powerful antipsychotic Seroquel caused diabetes, weight gain and other health problems.

Patients deserve facts about drug
Source: St. Petersburg Times > Local News

Big Pharma doing business as usual; they spend millions of dollars to push their drugs in order to make billions regardless of the ill effects of these drugs--business as usual.

AstraZeneca Drug Raises Diabetes Risk, Doctor Says (Update2)
Source: Bloomberg.com

AstraZeneca Plc's antipsychotic drug Seroquel raised by almost 400 percent the risk of developing diabetes when compared with first-generation medications in its class, a doctor testified in a court case against the drugmaker.

AstraZeneca row as corruption claims engulf Nobel prize - Times Online
Source: The Times

conflicts of interest and ethical lapses revealed in the Nobel Prize for Medicine winner

Crestor has been named one of the top five most dangerous drugs by the FDA. Yet it's being sold as immortality in a bottle.
Source: AlterNet.org

When Dr. Paul Ridker of Brigham and Women's Hospital in Boston presented the results of the AstraZeneca-funded JUPITER study at the American Heart Association conference in November, there were a lot more stenographers than skeptics in the press corps.

Rolls-Royce, AstraZeneca and Bae join list of job-cutting giants
Source: Guardian Unlimited

Thousands more jobs were axed today by some of Britain's leading companies, including Rolls-Royce, AstraZeneca and BAE Systems. In total, almost 4,000 posts are being cut from their global workforces, including about 600 in the UK.

Chemo can be Replaced with Pill
Source: Road Runner High Speed

Pill as good as chemo on lung cancer, but costlier However, the pill, called Iressa, is olny approved in the U.S. for patients who have failed chemotherapy. The drug tends to work better in patients who have never smoked, Asians, women and those with a certain genetic profile.

This area needs news. Click here to seed the vine